AstraZeneca Probe in China Adds to Concerns for Foreign Businesses

An investigation involving the drugmaker’s China president is the latest industry crackdown to trigger uncertainty about Beijing’s intentions.

Leave a Reply

Your email address will not be published. Required fields are marked *